Measurement of local cerebral glucose metabolism (lCMRGlc) by positron emission
tomography (PET) and 18 F-2-fluoro-2-deoxy-d-glucose (FDG) has become a standard …

The (F-18) fluorodeoxyglucose (FDG) technique to measure local cerebral metabolic rate for
glucose (LCMRglu) is well accepted and widely used by many institutions around the world …

Positron emission tomography (PET) with 18 F-2-fluoro-2-deoxy-D-glucose (FDG)
demonstrates a typical pattern of impairment of regional metabolic rates of glucose …

Positron emission tomography (PET) is a well-established imaging modality. Measurement
of regional cerebral glucose metabolism (rCMRglc) using PET and [18F]-2-fluoro-2-deoxy-d …

The diagnosis of dementia syndromes can be challenging for clinicians, particularly in the
early stages of disease. Patients with higher education levels may experience a marked …

The demographics of aging suggest a great need for the early diagnosis of dementia and
the development of preventive strategies. Neuropathology and structural MRI studies have …

There is increasing use of neuroimaging modalities, including PET, for diagnosing
dementia. For example, FDG-PET demonstrates hypometabolic regions in the posterior …

Regional cerebral glucose metabolism (rCMRGl) measured by positron emission
tomography of 18F-2-fluoro-2-deoxy-D-glucose was studied longitudinally (interval ranging …

Methods To evaluate the diagnostic power of cerebral metabolic distribution patterns for"
cortical" degenerative dementias, PET scans obtained from 129 patients referred for …

Purpose The purpose of the study was the identification of group and individual subject
patterns of cerebral glucose metabolism (CMRGlu) in patients with Alzheimer's disease (AD) …